Eidos Therapeutics Competitors and Similar CompaniesClear all
Eidos Therapeutics's competitors and similar companies include Biogen.
 Eidos Therapeutics Eidos Therapeutics is a biotech company developing novel, genetically targeted therapies to improve the lives of patients. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 2013 | Founding Date 1978 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ San Francisco, US | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 4513% increase | Employees 7,605 |
Valuation ($) | Valuation ($) 4.8 b | Valuation ($) 26.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $26.7m (FY, 2019) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods $2.5m (FY, 2019) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit $24.2m (FY, 2019) | Gross profit $7.5b (FY, 2025) |
Net income | Net income ($37.8m) (FY, 2019) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company